26.07.2013 Views

Untitled - D Ank Unlimited

Untitled - D Ank Unlimited

Untitled - D Ank Unlimited

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

Bcl-2 proteins 103 Bence–Jones (B–J) proteins<br />

the endosome induces a conformational change in diphtheria<br />

toxin that triggers membrane insertion of the membranespanning<br />

domains. Pore formation by dimerization is<br />

thought to occur, and the toxic subunit diphtheria toxin is<br />

translocated from the endosomal lumen into the cytosol. It<br />

is clear from reconstitution assays that many members of<br />

the Bcl-2 family can form a pore that allows passage of ions<br />

or elicits the release of cytochrome c from isolated mitochondria.<br />

Passage of ions is more dramatic at low pH. The<br />

carboxyl mitochondria targeting sequence is not required<br />

for in vitro pore formation.<br />

Bcl-2 proteins<br />

Proteins that regulate the rate at which apoptotic signaling<br />

events initiate or amplify caspase activity. Bcl-2 alters the<br />

apoptotic threshold of a cell rather than inhibiting a specific<br />

step in programmed cell death. Cells that overexpress<br />

Bcl-2 still carry out programmed cell death in response to<br />

a wide spectrum of apoptotic initiators. The dose of the<br />

initiator is greater than in the absence of Bcl-2. Several<br />

Bcl-2-related proteins have been identified. Whereas<br />

some Bcl-2 family members promote cell survival, others<br />

enhance the sensitivity of a cell to programmed death.<br />

Five homologs of Bcl-2 with antiapoptotic properties<br />

include Bcl-x L, Bcl-w, Mcl-l, NR-13, and A-1. By contrast,<br />

two proapoptotic members of the Bcl-2 family include Bax<br />

and Bak. Bcl-2-related proteins are present in the intracellular<br />

membranes, including the endoplasmic reticulum,<br />

outer mitocondrial membrane, and outer nuclear membrane.<br />

Bcl-2 proteins are hypothesized to regulate membrane<br />

permeability.<br />

Bcl-X L<br />

A Bcl-2-related protein that is upregulated through the<br />

action of the costimulatory molecules CD28 and CD40.<br />

Bcl-X L expression is claimed to prevent cell death in<br />

response to growth factor limitation or Fas signal transduction.<br />

Signal transduction through CD28 or CD40 induces<br />

Bcl-X L expression only in antigen-activated cells. Without<br />

antigen–receptor engagement, CD40 engagement promotes<br />

cell death. Bcl-x L induction by either CD28 or CD40 is transient,<br />

persisting only 3 to 4 days. Protection of cells from<br />

death lasts only as long as Bcl-x L is expressed.<br />

BCR/cABL<br />

Fusion gene that can be detected by either chromosomal<br />

analysis or polymerase chain reaction (PCR)-based<br />

molecular assays. There is also a total lack of leukocyte<br />

alkaline phosphatase.<br />

BDB<br />

Refer to bis-diazotized benzidine.<br />

Behçet’s disease<br />

Oral and genital ulcers, vasculitis, and arthritis that recur as<br />

a chronic disease in young men. It is postulated to have an<br />

immunologic basis and possibly to be immune complex-mediated.<br />

Perivascular infiltrates of lymphocytes may occur.<br />

The serum contains immune complexes, and immunofluorescence<br />

may reveal autoantibodies against the oral mucous<br />

membrane. It is associated with HLA-1 in ethnic groups,<br />

but not Caucasians. The principal immunologic dysfunction<br />

in Behçet’s disease is neutrophil hyperfunction, shown<br />

by augmented chemotactic responsiveness and superoxide<br />

production. Behçet’s disease is an inflammatory condition<br />

of uncertain cause. No autoimmune mechanism has been<br />

proven.<br />

Emil Adolph von Behring (1854–1917).<br />

Emil Adolph von Behring with colleagues in the laboratory.<br />

Behring, Emil Adolph von (1854–1917)<br />

German bacteriologist who, with Kitasato, demonstrated<br />

that circulating antitoxins against diphtheria and tetanus<br />

conferred immunity. Received the first Nobel Prize for<br />

Medicine in 1901 for this work. (Related works include<br />

Die Blutserumtherapie, 1902; Gesammelte Abhandlungen,<br />

1915; Behring, Gestalt und Werk, 1940; Emil von Behring<br />

zum Gedachtnis, 1942.)<br />

beige mice<br />

A mutant strain of mice that develops abnormalities<br />

in pigment, defects in natural killer cell function, and<br />

heightened tumor incidence, serving as a model for the<br />

Chediak–Higashi disease in humans. There is a defect in<br />

granule function. The strain has also been used as an NK<br />

cell-deficient murine model.<br />

Benacerraf, Baruj (1920–)<br />

American immunologist born in Caracas, Venezuela. His<br />

multiple contributions include the carrier effect in delayedtype<br />

hypersensitivity, lymphocyte subsets, major histocompatibility<br />

complex (MHC), and Ir immunogenetics, for<br />

which he received the Nobel Prize in 1980. (Benacerraf,<br />

B. and Unanue, E., Textbook of Immunology, Williams &<br />

Wilkins, Baltimore, Maryland, 1979.)<br />

Bence–Jones (B–J) proteins<br />

Represent the light chains of either the κ or λ variant<br />

excreted in the urine of patients with a paraproteinemia as<br />

B

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!